Polymyositis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions:   Dermatomyositis;   PolymyositisInterventions:   Drug: tocilizumab;   Drug: placeboSponsors:   University of Pittsburgh;   Genentech, Inc.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2014 Category: Research Source Type: clinical trials

Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions:   Dermatomyositis;   PolymyositisInterventions:   Drug: tocilizumab;   Drug: placeboSponsors:   University of Pittsburgh;   Genentech, Inc.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2014 Category: Research Source Type: clinical trials